Samlyn Capital’s Ingevity NGVT Stock Holding History

Samlyn Capital’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-216,995	Closed	-$11.4M	–	164
2020 Q2	$11.4M	Buy	+216,995	New	+$10.3M	0.21%	84

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Samlyn Capital's NGVT Position: Q3 2020 in Review

Samlyn Capital sold out of Ingevity (NGVT) in Q3 2020, closing a stake of 216,995 shares — an estimated $11.4M sold.

Samlyn Capital first reported a position in NGVT in Q2 2020 and held it in 1 quarter. The position peaked at $11.4M in Q2 2020. 283 funds tracked by Wall St. Rank hold NGVT as of Q3 2020.

Samlyn Capital reported no remaining Ingevity position as of Q3 2020 after selling out during the quarter.
Samlyn Capital sold 216,995 Ingevity shares in Q3 2020, an estimated $11.4M.
Samlyn Capital first reported a position in Ingevity in Q2 2020 and held it in 1 quarter.
Samlyn Capital's Ingevity position peaked at $11.4M in Q2 2020.
283 funds tracked by Wall St. Rank held Ingevity as of Q3 2020.

Based on Samlyn Capital's 13F filing for Q3 2020, filed 16 Nov 2020.